CVS Health to Split into Two by Separating Pharmacy and Insurance Businesses

The stock is trading above its 20‑day (89.88) and 50‑day (90.74) simple moving averages at 91.47. Its RSI sits at 62.5, approaching over‑bought territory, indicating positive but limited momentum. The MACD is now above the signal line (0.07 versus –0.29), giving a new bullish crossover signal that supports short‑term optimism. However, the ultimate impact of the split announcement remains uncertain, and market reaction could be volatile until details are clarified, so I am not assigning high conviction. I expect a modest upward trend over a 1‑3‑day window, but profit taking may occur near the 92‑93 resistance zone.

The news is not directly related to GOOGL; the CVS Health spinoff does not affect Alphabet's core operations, so the impact is largely neutral. The technical picture is weak: the price is below the SMA20 and SMA50, MACD is in negative territory, and RSI at 36 confirms weak momentum. In the short term, the SMA20 around 280 can be watched as resistance, with the 275-276 band as support. Since there is no news-driven catalyst, directional uncertainty persists; the current trend is slightly downward. Therefore, a neutral-to-bearish course is expected in the 1-3 day outlook.